Characteristics | Total (n = 4305) | Adverse fetal outcome (n = 218, 5.06%) | cOR (95%CI) | aOR (95%CI) | |
---|---|---|---|---|---|
 | No. | No. | % |  |  |
Maternal age (years) | Â | Â | Â | Â | Â |
<20 | 108 | 5 | 4.6 | 1@ | 1@ |
20-24 | 666 | 50 | 7.5 | 1.68 (0.65-4.31) | 1.39(0.51-3.76) |
25-29 | 1084 | 62 | 5.7 | 1.26 (0.49-3.19) | 1.23(0.45-3.34) |
30+ | 2447 | 101 | 4.1 | 0.89 (0.38-2.53) | 0.86(0.31-2.40) |
Gravidity | Â | Â | Â | Â | Â |
One | 849 | 57 | 6.7 | 1@ | 1@ |
Two | 651 | 39 | 6.0 | 0.89 (0.58-1.35) | 1.14(0.59-2.20) |
Three | 538 | 22 | 4.1 | 0.59(0.36-1.00) | 0.94(0.42-2.08) |
Four or more | 2267 | 100 | 4.4 | 0.64 (0.46-0.90)** | 1.35(0.62-2.90) |
Parity | Â | Â | Â | Â | Â |
Nulliparity (0 births) | 9.5 | 72 | 6.9 | 1@ | 1@ |
Multiparity (1-4 births) | 56.0 | 100 | 4.8 | 0.68 (0.50-0.93)** | 0.71((0.37-1.36) |
Grand multiparity(5+ births) | 34.5 | 46 | 3.9 | 0.55(0.38-0.80)** | 0.61(0.28-1.32) |
Gestational age | Â | Â | Â | Â | Â |
37-42Â weeks (term) | 3392 | 98 | 2.9 | 1@ | 1@ |
<37Â weeks (preterm) | 782 | 118 | 15.2 | 5.99 (4.52-7.92)** | 4.57(3.33-6.28)** |
>42Â weeks (postterm) | 131 | 2 | 1.5 | 0.52 (0.13-2.13) | 0.51(0.12-2.12) |
Twinning | 217 | 36 | 16.6 | 1.25 (2.89-6.26)** | 1.81(1.25-2.61)** |
GDM | 807 | 30 | 3.7 | 0.68 (0.46-1.01) | 0.66(0.43-1.01) |
Maternal comorbidity | 620 | 34 | 5.5 | 1.12 (0.76-1.61) | 0.98(0.65-1.47) |
Preeclampsia | 209 | 35 | 16.7 | 4.28(2.89-6.34)** | 2.74(1.75-4.30)** |
Hydramnios | 235 | 49 | 21.1 | 6.16 (4.34-8.75)** | 6.70(4.4.57-9.83)** |